Todd Sisitsky - Iqvia Holdings Director

<div class='circular--portrait' style='background:#0D52D1;color: white;font-size:5em;padding-top: 5px;;'>Q</div>
  Director
Mr. Todd Benjamin Sisitsky is Independent Director of the Company. Prior to his role at the Company, Mr. Sisitsky served as a director of IMS Health since February 2010. Mr. Sisitsky is a Partner of TPG, where he serves as Managing Partner of TPG Capital business in the U.S. and E.U. and coleads the firms investment activities in the healthcare services and pharmaceuticalmedical device sectors. Mr. Sisitsky serves on the boards of directors of Adare Pharmaceuticals, Endo International PLC, IASIS Healthcare Corporationrationration, Immucor Inc. and Surgical Care Affiliates, Inc. He previously served on the boards of directors of Par Pharmaceuticals Companies, Inc. and Zimmer Biomet Holdings, Inc. . He also serves on the board of the Campaign for Tobacco Free Kids, a global notforprofit organization, and the Dartmouth Medical School Board of Overseers. Prior to joining TPG in 2003, Mr. Sisitsky worked at Forstmann Little Company and Oak Hill Capital Partners. Mr. Sisitsky earned an M.B.A. from the Stanford Graduate School of Business, where he was an Arjay Miller Scholar, and earned his undergraduate degree from Dartmouth College, where he graduated summa cum laude. Mr. Sisitsky serves as a member of the LDCC and as a member of the Nominating and Governance Committee.
Age: 44  Director Since 2016  MBA    
919-998-2000  www.quintiles.com
Sisitsky earned an M.B.A. from the Stanford Graduate School of Business, where he was an Arjay Miller Scholar, and earned his undergraduate degree from Dartmouth College, where he graduated summa cum laude.

Management Efficiency

The company has return on total asset of 4.03 % which means that for every 100 dollars spent on asset it generated profit of $4.03. This is acceptable considering the industry classification. Similarly, it shows return on equity (ROE) of 1.89 % implying that it made 1.89 on every $100 invested by shareholders.
The company has accumulated 9.77 B in total debt with debt to equity ratio (D/E) of 130.0 implying that the company may be unable to produce cash to meet its debt commitments. Iqvia Holdings has Current Ratio of 1.2 implying that it may have difficulties to pay its interest payments when they become due.

Similar Executives

Showing few of many executives

DIRECTOR Since

Francisco PapathanasiadisPETROBRAS PN N2
2016
Durval SantosPETROBRAS PN N2
2016
Sadayuki SakakibaraNIPPON TEL TEL CORP
2012
Guilherme FerreiraPETROBRAS PN N2
2015
Marcelo SiqueiraPETROBRAS PN N2
2016
Myeong LeeSK Innovation
2019
Eiichi SakamotoNIPPON TEL TEL CORP
2018
Katsuhiko ShiraiNIPPON TEL TEL CORP
2012
Jeong YuSK Innovation
2016
Min HahnSK Innovation
2015
Eon ShinSK Innovation
2013
Takashi HiroiNIPPON TEL TEL CORP
2015
Jae LeeSK Innovation
2010
Jun SawadaNIPPON TEL TEL CORP
2018
Akira ShimadaNIPPON TEL TEL CORP
2018
Jeronimo AntunesPETROBRAS PN N2
2019
Deyvid SilvaPETROBRAS PN N2
2015
Sonia VillalobosPETROBRAS PN N2
2018
Yeong KimSK Innovation
2010
Ryota KitamuraNIPPON TEL TEL CORP
2018
Min HanSK Innovation
2015

Entity Summary

Quintiles IMS Holdings, Inc. offer biopharmaceutical development services and commercial outsourcing services in the Americas, Europe, Africa, and the AsiaPacific. Iqvia Holdings (Q) is traded on BATS Exchange in USA and employs 36,100 people.

Iqvia Holdings Leadership Team

Thomas Pike, CEO and Director
Ari Bousbib, Director
Michael Evanisko, Independent Director
Leonard Schaeffer, Independent Director
James Erlinger, Executive Vice President General Counsel, Secretary
John Danhakl, Director
Richard Staub, President - Research and Development Solutions
Michael McDonnell, CFO, Executive Vice President
Kevin Gordon, COO
John Leonard, Independent Director
James Fasano, Director
Jonathan Coslet, Director
John Connaughton, Director
Haiyuan Lo, Director
Ronald Rittenmeyer, Director
Dennis Gillings, Executive Chairman of the Board
Todd Sisitsky, Director
Jack Greenberg, Independent Director
Kevin Knightly, President - Information and Technology Solutions

Stock Performance Indicators

Current Sentiment - Q

Iqvia Holdings Investor Sentiment

More than half of Macroaxis users are at this time bullish on Iqvia Holdings. What is your judgment towards investing in Iqvia Holdings? Are you bullish or bearish?
Bullish
Bearish
98% Bullish
2% Bearish
Skip

Currently Active Assets on Macroaxis

USRT   
Purchased few shares of
a day ago
Traded for 55.68
IJR   
Purchased few shares of
a day ago
Traded for 85.37
IJH   
Purchased one share of
a day ago
Traded for 209.15
IVV   
Purchased one share of
a day ago
Traded for 333.5
IDEV   
Purchased few shares of
a day ago
Traded for 59.01
See also Your Equity Center. Please also try Money Flow Index module to determine momentum by analyzing money flow index and other technical indicators.